Morning ACR 'best' for spotting renal disease in diabetes

Renal events in people with type-2 diabetes are best predicted from albumin:creatinine ratio (ACR) derived from a first-morning void, a Dutch study shows.

Hiddo Heerspink and colleagues from the University of Groingen studied 701 patients with type-2 diabetes and nephropathy.

They compared four tests for predicting renal events. Two involved from 24-hour urine collection: urinary protein excretion (UPE); urinary albumin excretion (UAE). Two used samples from patients’ first-morning void: prinary albumin concentration (UAC) and ACR.

ACR measurements were able to predict over 33% more renal outcomes than the other tests.

Writing in the Journal of the American Society of Nephrology, the researchers said: 'The ACR derived from a first-morning void displayed the strongest association with the risk for renal events.'

They added: ‘The predictive value of the first- morning void albumin:creatinine ratio was significantly higher than 24-hour urinary albumin excretion or protein excretion and confirmed the superiority of the first-morning void albumin: creatinine ratio in predicting renal events.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus